Syros Pharmaceuticals Inc.(SYRS)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

SYRS Syros Pharmaceuticals Inc.

盘后交易 12-23 16:59:14 EST

0.2039

+0.0039

+1.95%

盘后0.2001

-0.0038-1.86%

16:43 EST

最高0.2053	最低0.1945	成交量99.58万
今开0.2025	昨收0.2000	日振幅5.40%
总市值547.11万	流通市值267.96万	总股本2,683万
成交额20.10万	换手率7.58%	流通股本1,314万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"SYRS","market":"US","secType":"STK","nameCN":"Syros Pharmaceuticals Inc.","latestPrice":0.2039,"timestamp":1734987599999,"preClose":0.2,"halted":0,"volume":995843,"hourTrading":{"tag":"盘后","latestPrice":0.2001,"preClose":0.2039,"latestTime":"16:43 EST","volume":293,"amount":58.89220304,"timestamp":1734990189109},"delay":0,"floatShares":13141646,"shares":26832457,"eps":-2.659099,"marketStatus":"盘后交易","marketStatusCode":4,"change":0.0039,"latestTime":"12-23 16:59:14 EST","open":0.2025,"high":0.2053,"low":0.1945,"amount":200973.10734972,"amplitude":0.054,"askPrice":0.2052,"askSize":306,"bidPrice":0.1838,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-2.659099,"exchange":"NASDAQ","tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1735002000000},"adr":0,"listingDate":1467259200000,"adjPreClose":0.2,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":0.21,"preClose":0.2,"latestTime":"09:27 EST","volume":29175,"amount":5938.4014515,"timestamp":1734964078905},"postHourTrading":{"tag":"盘后","latestPrice":0.2001,"preClose":0.2039,"latestTime":"16:43 EST","volume":293,"amount":58.89220304,"timestamp":1734990189109},"volumeRatio":0.523432,"impliedVol":1.268,"impliedVolPercentile":0.498},"requestUrl":"/m/hq/s/SYRS","defaultTab":"news","newsList":[{"id":"2491637242","title":"Syros Pharmaceuticals, Inc.盘中异动 早盘股价大跌5.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2491637242","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491637242?lang=zh_cn&edition=full","pubTime":"2024-12-13 23:28","pubTimestamp":1734103727,"startTime":"0","endTime":"0","summary":"北京时间2024年12月13日23时28分，Syros Pharmaceuticals, Inc.股票出现异动，股价急速跳水5.56%。Syros Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.41%。其相关个股中，Oculis Holding Ag C/Wts 06/03/2028 、Cardiff Oncology, Inc.、Gt Biopharma, Inc.涨幅较大，Aptevo Therapeutics Inc.、Palisade Bio, Inc.、Candel Therapeutics, Inc.较为活跃，换手率分别为53.66%、48.16%、32.02%，振幅较大的相关个股有Klotho Neurosciences Inc C/Wts 21/06/2029 、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 、Tc Biopharm  Plc C/Wts 10/02/2028 ，振幅分别为43.30%、43.12%、39.33%。Syros Pharmaceuticals, Inc.公司简介：Syros Pharmaceuticals Inc 是一家生物制药公司，致力于为血液恶性肿瘤患者的一线治疗制定新的护理标准。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121323284795e9797a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121323284795e9797a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SYRSW","BK4139","SYRS"],"gpt_icon":0},{"id":"2488094906","title":"Syros Pharmaceuticals, Inc.盘中异动 大幅下跌5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2488094906","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488094906?lang=zh_cn&edition=full","pubTime":"2024-12-03 01:23","pubTimestamp":1733160239,"startTime":"0","endTime":"0","summary":"北京时间2024年12月03日01时23分，Syros Pharmaceuticals, Inc.股票出现异动，股价大幅下挫5.12%。Syros Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.03%。其相关个股中，Senti Biosciences, Inc.、Purple Biotech Ltd、Cingulate Inc C/Wts 10/12/2026 涨幅较大，Senti Biosciences, Inc.、Purple Biotech Ltd、Quoin Pharmaceuticals Ltd较为活跃，换手率分别为2239.51%、2233.79%、605.61%，振幅较大的相关个股有Senti Biosciences, Inc.、Purple Biotech Ltd、Quoin Pharmaceuticals Ltd，振幅分别为481.02%、289.12%、131.67%。Syros Pharmaceuticals, Inc.公司简介：Syros Pharmaceuticals Inc 是一家生物制药公司，致力于为血液恶性肿瘤患者的一线治疗制定新的护理标准。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120301235998e4f160&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120301235998e4f160&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SYRSW","SYRS"],"gpt_icon":0},{"id":"2486821002","title":"Syros Pharmaceuticals, Inc.盘中异动 股价大跌6.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2486821002","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486821002?lang=zh_cn&edition=full","pubTime":"2024-11-26 23:01","pubTimestamp":1732633284,"startTime":"0","endTime":"0","summary":"北京时间2024年11月26日23时01分，Syros Pharmaceuticals, Inc.股票出现异动，股价大幅下跌6.18%。Syros Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.42%。其相关个股中，Poseida Therapeutics, Inc.、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、Protagenic Therapeutics, Inc.涨幅较大，Elevai Labs, Inc.、Oncternal Therapeutics, Inc.、木薯科学较为活跃，换手率分别为20.51%、16.46%、16.19%，振幅较大的相关个股有Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、Protagenic Therapeutics, Inc.、Citius Pharmaceuticals, Inc.，振幅分别为61.69%、42.94%、31.35%。Syros Pharmaceuticals, Inc.公司简介：Syros Pharmaceuticals Inc 是一家生物制药公司，致力于为血液恶性肿瘤患者的一线治疗制定新的护理标准。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241126230124971a8a69&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241126230124971a8a69&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SYRSW","BK4139","SYRS"],"gpt_icon":0},{"id":"2486038454","title":"Syros Pharmaceuticals, Inc.盘中异动 早盘快速下跌5.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2486038454","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486038454?lang=zh_cn&edition=full","pubTime":"2024-11-25 22:33","pubTimestamp":1732545182,"startTime":"0","endTime":"0","summary":"北京时间2024年11月25日22时33分，Syros Pharmaceuticals, Inc.股票出现波动，股价快速下挫5.53%。Syros Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.06%。其相关个股中，Scholar Rock Holding Corporation、Citius Pharmaceuticals, Inc.、Bridgebio Pharma, Inc.涨幅较大，Cognition Therapeutics, Inc.、木薯科学、Citius Pharmaceuticals, Inc.较为活跃，换手率分别为86.46%、60.14%、38.05%，振幅较大的相关个股有Anixa Biosciences, Inc.、Werewolf Therapeutics, Inc.、Kodiak Sciences Inc，振幅分别为105.47%、105.26%、105.01%。Syros Pharmaceuticals, Inc.公司简介：Syros Pharmaceuticals Inc 是一家生物制药公司，致力于为血液恶性肿瘤患者的一线治疗制定新的护理标准。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125223302971a85a5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125223302971a85a5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SYRS","SYRSW","BK4139"],"gpt_icon":0},{"id":"2486705257","title":"单月超6亿美元，医药企业IPO规模重返疫情前水平","url":"https://stock-news.laohu8.com/highlight/detail?id=2486705257","media":"财通社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486705257?lang=zh_cn&edition=full","pubTime":"2024-11-25 17:34","pubTimestamp":1732527240,"startTime":"0","endTime":"0","summary":"今年以来，生物医药领域已经有30家公司IPO上市，累计融资规模超40.49亿美元，其中不乏CG Oncology、Kyverna Therapeutics等IPO规模超3亿美元的公司。在多肽类PTH1R激动剂领域，阿斯利康以总价18亿美元收购AmolytPharma，获得了处于临床3期的PTH1R激动剂eneboparatide，目前该疗法已经获得了FDA快速通道认定，另一家药企AscendisPharma的Yorvipath获得FDA批准上市，用于治疗成人慢性甲状旁腺功能减退。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2024-11-25/doc-incxhqmk8147031.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4599","BK4539","BK4082","SEPN","BDMD","TQQQ","BK4200","BK4561","BK4139","BK4007","PSQ","QID","QLD",".IXIC","GPCR","SYRS","SQQQ","OMGA","AVTE","CAMP","BK4020","ASO","UPB","TSLP","GLYC","NQmain","MNQmain","APGE"],"gpt_icon":1},{"id":"2485920262","title":"Syros Pharmaceuticals, Inc.盘中异动 早盘急速上涨5.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485920262","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485920262?lang=zh_cn&edition=full","pubTime":"2024-11-22 23:06","pubTimestamp":1732287982,"startTime":"0","endTime":"0","summary":"北京时间2024年11月22日23时06分，Syros Pharmaceuticals, Inc.股票出现异动，股价急速拉升5.38%。Syros Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.34%。其相关个股中，Replimune Group, Inc.、Virpax Pharmaceuticals, Inc.、Exicure, Inc.涨幅较大，Virpax Pharmaceuticals, Inc.、Exicure, Inc.、Molecular Templates, Inc.较为活跃，换手率分别为1438.06%、103.68%、79.27%，振幅较大的相关个股有Virpax Pharmaceuticals, Inc.、Exicure, Inc.、Invizyne Technologies Inc.，振幅分别为48.21%、42.36%、33.30%。Syros Pharmaceuticals, Inc.公司简介：Syros Pharmaceuticals Inc 是一家生物制药公司，致力于为血液恶性肿瘤患者的一线治疗制定新的护理标准。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122230622abd7a1f9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122230622abd7a1f9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SYRSW","SYRS","BK4139"],"gpt_icon":0},{"id":"2484988806","title":"BUZZ-因 QIAGEN 交易终止和领导层变动，Syros 制药公司创历史新低","url":"https://stock-news.laohu8.com/highlight/detail?id=2484988806","media":"路透中文","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484988806?lang=zh_cn&edition=full","pubTime":"2024-11-19 03:43","pubTimestamp":1731959009,"startTime":"0","endTime":"0","summary":"由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241118:nL4T3MP1E6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["QGEN","BK4121","LU2125909593.SGD","BK4139","LU2433249047.HKD","LU2125909247.SGD","LU1923622614.USD","SYRS"],"gpt_icon":0},{"id":"2484679824","title":"Syros Pharmaceuticals, Inc.盘中异动 股价大跌5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484679824","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484679824?lang=zh_cn&edition=full","pubTime":"2024-11-18 22:32","pubTimestamp":1731940379,"startTime":"0","endTime":"0","summary":"北京时间2024年11月18日22时32分，Syros Pharmaceuticals, Inc.股票出现异动，股价急速下跌5.13%。Syros Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.30%。其相关个股中，Hcw Biologics Inc.、冠科美博、Fate Therapeutics, Inc.涨幅较大，Tharimmune, Inc.、Hcw Biologics Inc.、冠科美博较为活跃，换手率分别为517.22%、208.47%、189.28%，振幅较大的相关个股有Hcw Biologics Inc.、冠科美博、Fate Therapeutics, Inc.，振幅分别为50.92%、34.31%、27.23%。Syros Pharmaceuticals, Inc.公司简介：Syros Pharmaceuticals Inc 是一家生物制药公司，致力于为血液恶性肿瘤患者的一线治疗制定新的护理标准。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111822325998e433cc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111822325998e433cc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SYRS","SYRSW"],"gpt_icon":0},{"id":"2483377114","title":"Syros Pharmaceuticals, Inc.盘中异动 股价大跌6.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483377114","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483377114?lang=zh_cn&edition=full","pubTime":"2024-11-15 22:31","pubTimestamp":1731681105,"startTime":"0","endTime":"0","summary":"北京时间2024年11月15日22时31分，Syros Pharmaceuticals, Inc.股票出现波动，股价快速下跌6.51%。Syros Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.69%。其相关个股中，Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Cero Therapeutics Holdings, Inc.、Tc Biopharm  Plc涨幅较大，Tc Biopharm  Plc、Elevai Labs, Inc.、Cero Therapeutics Holdings, Inc.较为活跃，换手率分别为2760.31%、163.43%、66.91%，振幅较大的相关个股有Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Cero Therapeutics Holdings, Inc.、Pulmatrix, Inc.，振幅分别为75.68%、42.74%、12.55%。Syros Pharmaceuticals, Inc.公司简介：Syros Pharmaceuticals Inc 是一家生物制药公司，致力于为血液恶性肿瘤患者的一线治疗制定新的护理标准。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111522314598e42ec1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111522314598e42ec1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SYRSW","SYRS"],"gpt_icon":0},{"id":"2483809088","title":"Syros Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.85%报0.380美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483809088","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483809088?lang=zh_cn&edition=full","pubTime":"2024-11-14 22:31","pubTimestamp":1731594698,"startTime":"0","endTime":"0","summary":"北京时间2024年11月14日22时31分，Syros Pharmaceuticals, Inc.股票出现波动，股价急速上涨5.85%。截至发稿，该股报0.380美元/股，成交量236.153万股，换手率8.80%，振幅5.57%。Syros Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.42%。Syros Pharmaceuticals, Inc.公司简介：Syros Pharmaceuticals Inc 是一家生物制药公司，致力于为血液恶性肿瘤患者的一线治疗制定新的护理标准。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111422313895be2c60&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111422313895be2c60&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SYRS","BK4139","SYRSW"],"gpt_icon":0},{"id":"2483833213","title":"BUZZ--美国股票走势-BankUnited, Natera, Adaptimmune","url":"https://stock-news.laohu8.com/highlight/detail?id=2483833213","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483833213?lang=zh_cn&edition=full","pubTime":"2024-11-14 00:01","pubTimestamp":1731513684,"startTime":"0","endTime":"0","summary":"        *      Eikon 个股走势搜索字符串：[STXBZ］        *      The Day Ahead 新闻通讯：          *      The Morning News Call时事通讯：      11月13日 - 周三，华尔街主要股指走高，因消费者价格通胀数据符合预期，使美国联邦储备理事会有望在12月再次降息。美国东部时间10:31，道琼斯工业平均指数  上涨0.10%，报43956.01点；标普500指数  下跌0.08%，报5979.25点；纳斯达克综合指数  下跌0.25%，报19232.38点。** BTC Digital Ltd   ，上涨 63.7  纳斯达克  百分比跌幅前三名：** Syros Pharmaceuticals Inc   ，下跌 86.1% ** GlucoTrack Inc   ，下跌 74.4 ** Wag！","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DXD","DJX","RIVN","COTY","NTRA","SQQQ","LXEO","KNX","POAI","PAY","HON","SYRS","ODFL",".SPX","VVX","NQmain","MNQmain","BKU","SAIA","QID","DDM","DAVE","CTRA","SPOT","ALB","ETNB","GEV","DOG","CAT","GDYN","CART","HTLD",".DJI","CAVA","SDOW","SWKS","SAVE","BRTX","ADAP","AMGN","PSQ","SSYS","QLD","TQQQ",".IXIC"],"gpt_icon":1},{"id":"2483884346","title":"Syros Pharmaceuticals, Inc.盘中异动 早盘快速下挫85.71%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483884346","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483884346?lang=zh_cn&edition=full","pubTime":"2024-11-13 22:31","pubTimestamp":1731508317,"startTime":"0","endTime":"0","summary":"北京时间2024年11月13日22时31分，Syros Pharmaceuticals, Inc.股票出现异动，股价快速下挫85.71%。Syros Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.05%。其相关个股中，Celularity Inc C/Wts 16/07/2026 、Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Mersana Therapeutics, Inc.涨幅较大，Cyclacel Pharmaceuticals, Inc.、Elevai Labs, Inc.、Tharimmune, Inc.较为活跃，换手率分别为329.53%、173.62%、84.71%，振幅较大的相关个股有Immunoprecise Antibodies Ltd.、Mersana Therapeutics, Inc.、Sangamo Therapeutics, Inc.，振幅分别为12.77%、10.27%、8.86%。Syros Pharmaceuticals, Inc.公司简介：Syros Pharmaceuticals Inc 是一家生物制药公司，致力于为血液恶性肿瘤患者的一线治疗制定新的护理标准。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113223200971a6471&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113223200971a6471&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SYRSW","BK4139","SYRS"],"gpt_icon":0},{"id":"2483971885","title":"BUZZ-血癌药物晚期试验失败，Syros 公司业绩下滑","url":"https://stock-news.laohu8.com/highlight/detail?id=2483971885","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483971885?lang=zh_cn&edition=full","pubTime":"2024-11-13 22:03","pubTimestamp":1731506586,"startTime":"0","endTime":"0","summary":"11月13日 -  ** Syros制药公司SYRS.O股价盘前下跌84.5%至42美分 ** 该公司周二表示，其药物tamibarotene在一项后期试验中没有达到治疗一种名为骨髓增生异常综合征的罕见血癌的高风险形式的主要目标 。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241113:nL4T3MK18Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SYRS"],"gpt_icon":0},{"id":"2482148509","title":"Syros Pharmaceuticals, Inc.2024财年第三财季实现净利润-6.40百万美元，同比增加84.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482148509","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482148509?lang=zh_cn&edition=full","pubTime":"2024-11-09 00:00","pubTimestamp":1731081632,"startTime":"0","endTime":"0","summary":"11月9日，Syros Pharmaceuticals, Inc.公布财报，公告显示公司2024财年第三财季净利润为-6.40百万美元，同比增加84.06%；其中营业收入为0.00美元，每股基本收益为-0.16美元。机构评级：截至2024年11月9日，当前有4家机构对Syros Pharmaceuticals, Inc.目标价做出预测，其中目标均价为8.75美元，其中最低目标价为4.00美元，最高目标价为20.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241109000234a224f724&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241109000234a224f724&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SYRS","SYRSW"],"gpt_icon":0},{"id":"2481180380","title":"Syros Pharmaceuticals, Inc.盘中异动 早盘股价大涨6.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481180380","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481180380?lang=zh_cn&edition=full","pubTime":"2024-11-07 23:31","pubTimestamp":1730993515,"startTime":"0","endTime":"0","summary":"北京时间2024年11月07日23时31分，Syros Pharmaceuticals, Inc.股票出现波动，股价大幅拉升6.09%。Syros Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.20%。其相关个股中，Celularity Inc.、Ensysce Biosciences, Inc.、Tevogen Bio Holdings Inc C/Wts 14/02/2029 涨幅较大，Ensysce Biosciences, Inc.、Elevai Labs, Inc.、Cyclacel Pharmaceuticals, Inc.较为活跃，换手率分别为677.84%、145.15%、92.89%，振幅较大的相关个股有Celularity Inc.、180 Life Sciences Corp C/Wts 07/11/2025、Ensysce Biosciences, Inc.，振幅分别为84.83%、68.89%、57.79%。Syros Pharmaceuticals, Inc.公司简介：Syros Pharmaceuticals Inc 是一家生物制药公司，致力于为血液恶性肿瘤患者的一线治疗制定新的护理标准。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241107233155971a5205&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241107233155971a5205&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SYRSW","SYRS","BK4139"],"gpt_icon":0},{"id":"2480879375","title":"Syros Pharmaceuticals, Inc.盘中异动 早盘快速拉升5.47%报2.39美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2480879375","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480879375?lang=zh_cn&edition=full","pubTime":"2024-11-04 23:25","pubTimestamp":1730733928,"startTime":"0","endTime":"0","summary":"北京时间2024年11月04日23时25分，Syros Pharmaceuticals, Inc.股票出现异动，股价快速上涨5.47%。Syros Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.28%。其相关个股中，Neurogene Inc.、Tenaya Therapeutics, Inc.、Disc Medicine, Inc.涨幅较大，Nls Pharmaceutics Ltd.、Elevai Labs, Inc.、Gri Bio, Inc.较为活跃，换手率分别为262.17%、246.95%、64.36%，振幅较大的相关个股有In8Bio, Inc.、Kazia Therapeutics Limited、Tc Biopharm  Plc C/Wts 10/02/2028 ，振幅分别为45.39%、39.13%、31.90%。Syros Pharmaceuticals, Inc.公司简介：Syros Pharmaceuticals Inc 是一家生物制药公司，致力于为血液恶性肿瘤患者的一线治疗制定新的护理标准。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104232528ab9ed5d2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104232528ab9ed5d2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SYRSW","BK4139","SYRS"],"gpt_icon":0},{"id":"2480882769","title":"Syros Pharmaceuticals, Inc.盘中异动 早盘大幅下挫14.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2480882769","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480882769?lang=zh_cn&edition=full","pubTime":"2024-11-01 21:31","pubTimestamp":1730467874,"startTime":"0","endTime":"0","summary":"北京时间2024年11月01日21时31分，Syros Pharmaceuticals, Inc.股票出现波动，股价大幅下跌14.88%。Syros Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.43%。其相关个股中，Tc Biopharm  Plc C/Wts 10/02/2028 、Theriva Biologics, Inc.、Athira Pharma, Inc.涨幅较大，Theriva Biologics, Inc.、Athira Pharma, Inc.、Elevai Labs, Inc.较为活跃，换手率分别为1173.94%、94.25%、72.51%，振幅较大的相关个股有Theriva Biologics, Inc.、Cyclerion Therapeutics, Inc.、Genelux Corporation，振幅分别为10.96%、9.34%、8.07%。Syros Pharmaceuticals, Inc.公司简介：Syros Pharmaceuticals Inc 是一家生物制药公司，致力于为血液恶性肿瘤患者的一线治疗制定新的护理标准。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110121311495bdaacd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110121311495bdaacd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","SYRS","SYRSW"],"gpt_icon":0},{"id":"2480045774","title":"Syros Pharmaceuticals Inc 报告截至 9 月 30 日的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2480045774","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480045774?lang=zh_cn&edition=full","pubTime":"2024-11-01 11:31","pubTimestamp":1730431861,"startTime":"0","endTime":"0","summary":"   * Syros Pharmaceuticals Inc   报告，截至9月30日的季度调整后每股亏损16美分，高于去年同期的每股收益1.43美元。五位分析师对该季度的平均预期是每股亏损 72 美分。华尔街预期为每股-78美分至-65美分。* Syros Pharmaceuticals Inc 报告的本季度每股收益为亏损 16 美分。* 该公司当季亏损 640 万美元。* Syros Pharmaceuticals Inc 本季度股价上涨了 16.7%，今年迄今为止亏损了 67.8%。华尔街对 Syros Pharmaceuticals Inc 的 12 个月目标价中位数为 10.00  本摘要由 LSEG 数据于 11 月 1 日 03:30 a.m. UTC 机器生成。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Syros Pharmaceuticals Inc 报告截至 9 月 30 日的季度业绩 - 收益摘要","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SYRS","BK4139"],"gpt_icon":0},{"id":"2479785320","title":"Syros Pharmaceuticals, Inc.盘中异动 股价大跌5.53%报2.39美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2479785320","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479785320?lang=zh_cn&edition=full","pubTime":"2024-10-30 21:30","pubTimestamp":1730295044,"startTime":"0","endTime":"0","summary":"北京时间2024年10月30日21时30分，Syros Pharmaceuticals, Inc.股票出现波动，股价快速跳水5.53%。Syros Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。其相关个股中，Tharimmune, Inc.、Ensysce Biosciences, Inc.、Biovie Inc.涨幅较大，Tharimmune, Inc.、Ensysce Biosciences, Inc.、Gri Bio, Inc.较为活跃，换手率分别为1594.55%、96.01%、13.86%，振幅较大的相关个股有Tharimmune, Inc.、Nanobiotix、Lixte Biotechnology Holdings, Inc.，振幅分别为5.40%、4.49%、3.85%。Syros Pharmaceuticals, Inc.公司简介：Syros Pharmaceuticals Inc 是一家生物制药公司，致力于为血液恶性肿瘤患者的一线治疗制定新的护理标准。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103021304498e3f64b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103021304498e3f64b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SYRS","BK4139","SYRSW"],"gpt_icon":0},{"id":"2479288285","title":"Syros Pharmaceuticals Inc    预计每股亏损 72 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2479288285","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479288285?lang=zh_cn&edition=full","pubTime":"2024-10-29 21:44","pubTimestamp":1730209484,"startTime":"0","endTime":"0","summary":"   * Syros Pharmaceuticals Inc    将于10月31日公布截至2024年9月30日的财报，预计季度收入将出现下降。* 根据LSEG的数据，4位分析师的平均预期显示，这家总部位于马萨诸塞州剑桥市的公司预计营收将从去年同期的376万美元下降88.0%至45万美元。* LSEG 分析师对 Syros Pharmaceuticals Inc 的平均预期是每股亏损 72 美分。* 华尔街对 Syros Pharmaceuticals Inc 的 12 个月目标价中位数为 10.00 美元，高于其最新收盘价 2.11 美元。10月29日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Syros Pharmaceuticals Inc    预计每股亏损 72 美分 - 财报前瞻","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SYRS"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.syros.com","stockEarnings":[{"period":"1week","weight":-0.0347},{"period":"1month","weight":-0.3103},{"period":"3month","weight":-0.8974},{"period":"6month","weight":-0.9642},{"period":"1year","weight":-0.9654},{"period":"ytd","weight":-0.9743}],"compareEarnings":[{"period":"1week","weight":-0.0221},{"period":"1month","weight":0.0006},{"period":"3month","weight":0.0397},{"period":"6month","weight":0.0851},{"period":"1year","weight":0.2499},{"period":"ytd","weight":0.243}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Syros Pharmaceuticals, Inc.于2011年11月9日根据特拉华州法律注册成立。该公司是一家生物制药公司，致力于为血液系统恶性肿瘤患者的一线治疗制定新的护理标准。该公司正在推进一项后期临床计划，其中包括候选主要产品：（i）Tamibarotene，一种选择性视黄酸受体α激动剂，该公司正在进行SELECT-MDS-1，这是一项3期临床试验，评估达菲与阿扎胞苷联合治疗高危骨髓增生异常综合征（HR-MDS）患者的基因组定义子集。（ii）SY-2101，一种新的口服形式的三氧化二砷或ATO，其在新诊断的低风险急性早幼粒细胞白血病或APL患者的剂量确认研究中进行评估。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.008745},{"month":2,"riseRate":0.5,"avgChangeRate":-0.093448},{"month":3,"riseRate":0.5,"avgChangeRate":0.03661},{"month":4,"riseRate":0.375,"avgChangeRate":-0.022337},{"month":5,"riseRate":0.625,"avgChangeRate":0.031071},{"month":6,"riseRate":0.625,"avgChangeRate":0.041503},{"month":7,"riseRate":0.333333,"avgChangeRate":-0.018345},{"month":8,"riseRate":0.666667,"avgChangeRate":0.059795},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.063091},{"month":10,"riseRate":0.222222,"avgChangeRate":-0.181851},{"month":11,"riseRate":0.333333,"avgChangeRate":-0.103908},{"month":12,"riseRate":0.333333,"avgChangeRate":0.150437}],"exchange":"NASDAQ","name":"Syros Pharmaceuticals Inc.","nameEN":"Syros Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Syros Pharmaceuticals Inc.(SYRS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Syros Pharmaceuticals Inc.(SYRS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Syros Pharmaceuticals Inc.,SYRS,Syros Pharmaceuticals Inc.股票,Syros Pharmaceuticals Inc.股票老虎,Syros Pharmaceuticals Inc.股票老虎国际,Syros Pharmaceuticals Inc.行情,Syros Pharmaceuticals Inc.股票行情,Syros Pharmaceuticals Inc.股价,Syros Pharmaceuticals Inc.股市,Syros Pharmaceuticals Inc.股票价格,Syros Pharmaceuticals Inc.股票交易,Syros Pharmaceuticals Inc.股票购买,Syros Pharmaceuticals Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Syros Pharmaceuticals Inc.(SYRS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Syros Pharmaceuticals Inc.(SYRS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}